Literature DB >> 6174231

Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.

E T Creagan, D L Ahmann, A J Schutt, S J Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6174231

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients.

Authors:  I G Ron; M J Inbar; M Gutman; O Merimsky; S Chaitchik
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

2.  Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.

Authors:  D Pectasides; H Yianniotis; N Alevizakos; D Bafaloukos; V Barbounis; J Varthalitis; M Dimitriadis; A Athanassiou
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.